Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes-Reference-Cited by-同舟云学术

Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes

Author:

Maze Dawn¹²,Kazi Sajida²³,Gupta Vikas¹²,Malinowski Ann Kinga²⁴,Fazelzad Rouhi¹²,Shah Prakesh S.²⁵,Shehata Nadine²⁵

Affiliation:

1. Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada

2. University of Toronto, Toronto, Ontario, Canada

3. Division of Hematology, University Health Network, Toronto, Ontario, Canada

4. Division of Maternal–Fetal Medicine, Department of Obstetrics & Gynaecology, Mount Sinai Hospital, Toronto, Ontario, Canada

5. Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

Reference55 articles.

2. Essential thrombocythemia.;Finazzi;Semin Hematol,2005

3. The management and outcome of 18 pregnancies in women with polycythemia vera.;Robinson;Haematologica,2005

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disorders of Blood, Coagulation, and Bone Marrow;Obstetric Anesthesia and Uncommon Disorders;2024-02-01

3. Essential Thrombocythemia in Pregnancy: A Case Report;European Journal of Medical and Health Sciences;2023-12-29

5. Polycythemia Vera;Cancer Consult;2023-11-18